Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

XC 101

Next Previous
X
Search
Drug Profile

XC 101

Alternative Names: XC101; XC101-D13H

Latest Information Update: 28 Nov 2022

Price :

$50 *

Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Xoc Pharmaceuticals
  • Class Antimigraines; Small molecules
  • Mechanism of Action 5-HT2C serotonin receptor antagonists; Serotonin 1B receptor agonists; Serotonin 1F receptor partial agonists; Serotonin 2B receptor antagonists; Serotonin 5-HT2A receptor antagonists; Serotonin 7 receptor agonists; Serotonin-1D-receptor partial agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Phase I/II Migraine

Most Recent Events

  • 28 Nov 2022 No recent reports of development identified for phase-I development in Migraine(Prevention) in USA (PO, Capsule)
  • 28 Nov 2022 Phase-I/II clinical trials in Migraine (Prevention) in USA (PO) (Xoc Pharmaceuticals pipeline, November 2022)
  • 08 Oct 2019 Phase-I clinical trials in Migraine (Prevention) in USA (PO, Capsule) (NCT04104399)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top